Recent studies have found that APOC1 promotes osteosarcoma progression through binding to MTCH2 [64], and preoperative APOB/APOA1 has been identified as an independent prognostic factor for osteosarcoma in children and adolescents [65]. Here, MTCH2 is linked to osteosarcoma.